Global Wound Care Biologics Market_Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

July 2018 | 397 pages | ID: G09A217CF80EN
Data Bridge Market Research

Abstracts

Global wound care biologics market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases aging population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for global wound care biologics s market are listed below:

• Smith and Nephew
• INTEGRA LIFE SCIENCES CORPORATION
• Mölnlycke Health Care AB
• Amnio Technology, LLC
• Alphatec Spine, Inc.
• BioHorizons IPH, Inc.
• ORGANOGENESIS INC
• CONVATEC AG
• Skye Biologics Inc.
• Anika Therapeutics, Inc.
• Osiris Therapeutics, Inc.
• Vericel Corporation
• MiMedx
• WRIGHT MEDICAL GROUP N.V.
• Kerecis
• ACell Inc.
• Solsys Medical
• Marine Polymer Technologies, Inc.
• Amniox Medical, Inc.
• Amniox Medical, Inc.

The global wound care biologics market is segmented into:

• Product Type
• Wound Type
• End User

On the basis of product type the global wound care biologics market is segmented into synthetic skin grafts, growth factors, allografts, xenografts. In 2018, synthetic skin grafts segment is expected to dominate the Global wound care biologics market with highest market shares. However, allografts segment is expected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF)segment, platelet rich plasma (PRP)segment, epidermal growth factor (EGF)segment and basic fibroblast growth factor (BFGF)segment, granulocyte colony stimulating factor (G-CSF) segment, talactoferrin alfa, thrombin peptide (TP508)segment, keratinocyte growth factor (KGF)segment.

On the basis of wound type the global wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segmentis expected to dominate the global wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.

On the basis of end user the global wound care biologics s market is segmented into hospitals, wound care centres and ambulatory centers, clinics, community healthcare centers. In 2018, hospitals are expected to dominate the global wound care biologics market with the highest market shares in the forecast period 2018 to 2025.

Based on geography, the market is segmented into 5 geographical regions:

• Europe
• North America
• Asia-Pacific
• South America
• Middle East & Africa

Covered in this report

The report covers the present scenario and the growth prospects of the global wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Contents

1 INTRODUCTION

1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Global Wound Care Biologics Market
1.4 Currency And Pricing
1.5 Limitation
1.6 Markets Covered

2 MARKET SEGMENTATION

2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.1 Dbmr Market Position Grid
2.2 Dbmr Market Challenge Matrix
2.3 Secondary Sources
2.4 Assumptions

3 MARKET OVERVIEW

3.1 Drivers
  3.1.1 Increasing Cases Of Diabetic Foot Ulcers
  3.1.2 Increasing Incidences Of Burn Cases
  3.1.3 Rising Number Of Geriatric Population
  3.1.4 Innovation In Wound Care Biologics
  3.1.5 New Product Launches
3.2 Restrains
  3.2.1 High Cost Of Wound Treatment And Wound Care Biologics
  3.2.2 Risk Of Skin Substitue Failure
3.3 Opportunities
  3.3.1 3D Skin Printing
  3.3.2 Awareness Programs
3.4 Challenges
  3.4.1 Lack Of Wound Management Services

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE

6.1 Overview
6.2 Synthetic Skin Grafts
6.3 Growth Factors
  6.3.1 Platelet Derived Growth Factor (Pdgf)
  6.3.2 Platelet Rich Plasma (Prp)
  6.3.3 Epidermal Growth Factors (Egf)
  6.3.4 Basic Fibroblast Growth Factors (Bfgf)
  6.3.5 Granulocyte Colony Stimulating Factor (G-Csf)
  6.3.6 Talactoferrin Alfa
  6.3.7 Thrombin Peptide
  6.3.8 Keratinocy Growth Factor (Kgf)
6.4 Allografts
6.5 Xenografts

7 GLOBAL WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE

7.1 Overview
7.2 Wounds
  7.2.1 Surgical Wound
    7.2.1.1 Skin Surgery
      7.2.1.1.1 Wound Closure
      7.2.1.1.2 Skin Biopsy
      7.2.1.1.3 Skin Flap
      7.2.1.1.4 Skin Graft
      7.2.1.1.5 Others
    7.2.1.2 Cosmetic Procedure
      7.2.1.2.1 Brest Enhancement
      7.2.1.2.2 Facial Contouring
      7.2.1.2.3 Facial Rejuvenation:
      7.2.1.2.4 Body Contouring
      7.2.1.2.5 Skin Rejuvenation
      7.2.1.2.6 Others
    7.2.1.3 Gynecologic Procedures
      7.2.1.3.1 Pubovaginalis Sling
      7.2.1.3.2 Pelvic Floor Reconstruction
      7.2.1.3.3 Rectocele Repair Surgery
      7.2.1.3.4 Others
    7.2.1.4 Gastrointestinal Procedure
      7.2.1.4.1 General Gastrointestinal Surgery
      7.2.1.4.2 Hernia
      7.2.1.4.3 Others
  7.2.2 Acute Wounds
  7.2.3 Chronic Wounds
  7.2.4 Traumatic Wounds
7.3 Burns
  7.3.1 Ulcers
  7.3.2 Diabetic Ulcers
  7.3.3 Pressure Ulcer
  7.3.4 Venous Ulcer
  7.3.5 Others

8 GLOBAL WOUND CARE BIOLOGICS MARKET, BY END USER

8.1 Overview
8.2 Hospitals
8.3 Wound Care Centers
8.4 Ambulatory Surgical Centers
8.5 Clinics
8.6 Community Healthcare Center

9 GLOBAL WOUND CARE BIOLOGICS MARKET: GEOGRAPHY

9.1 Global
9.2 North America
  9.2.1 U.S.
  9.2.2 Canada
  9.2.3 Mexico
9.3 Europe
  9.3.1 Germany
  9.3.2 France
  9.3.3 U.K.
  9.3.4 Italy
  9.3.5 Switzerland
  9.3.6 Netherlands
  9.3.7 Russia
  9.3.8 Turkey
  9.3.9 Spain
  9.3.10 Belgium
  9.3.11 Rest Of Europe
9.4 Asia-Pacific
  9.4.1 China
  9.4.2 Japan
  9.4.3 India
  9.4.4 South Korea
  9.4.5 Australia
  9.4.6 Thailand
  9.4.7 Malaysia
  9.4.8 Singapore
  9.4.9 Indonesia
  9.4.10 Philippines
  9.4.11 Rest Of Asia-Pacific
9.5 South America
  9.5.1 Brazil
  9.5.2 Rest Of South America
9.6 Middle East & Africa
  9.6.1 South Africa
  9.6.2 Rest Of Middle East & Africa

10 GLOBAL WOUND CARE BIOLOGICS MARKET, COMPANY LANDSCAPE

10.1 Company Share Analysis: Global
10.2 Company Share Analysis: North America
10.3 Company Share Analysis: Europe
10.4 Company Share Analysis: Asia-Pacific

11 COMPANY PROFILE

11.1 Mimedx.
  11.1.1 Company Overview
  11.1.2 Revenue Analysis:
  11.1.3 Company Share Analysis:
  11.1.4 Product Portfolio
  11.1.5 Recent Developments
11.2 Organogenesis Inc
  11.2.1 Company Overview
  11.2.2 Geographic Presence
  11.2.3 Company Share Analysis:
  11.2.4 Product Portfolio
  11.2.5 Recent Developments
11.3 Integra Lifesciences
  11.3.1 Company Overview
  11.3.2 Revenue Analysis
  11.3.3 Company Share Analysis:
  11.3.4 Product Portfolio
  11.3.5 Recent Developments
11.4 Convatec Inc.
  11.4.1 Company Overview
  11.4.2 Revenue Analysis
  11.4.3 Company Share Analysis:
  11.4.4 Product Portfolio:
  11.4.5 Recent Developments
11.5 Acell Inc.
  11.5.1 Company Overview
  11.5.2 Product Portfolio
  11.5.3 Recent Developments
11.6 Allosource
  11.6.1 Company Overview
  11.6.2 Product Portfolio
  11.6.3 Recent Developments
11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc)
  11.7.1 Company Overview
  11.7.2 Product Portfolio
  11.7.3 Recent Developments
11.8 Amnio Technology, Llc
  11.8.1 Company Overview
  11.8.2 Product Portfolio
  11.8.3 Recent Developments
11.9 Amniox Medical, Inc.
  11.9.1 Company Overview
  11.9.2 Product Portfolio
  11.9.3 Recent Developments
11.10 Anika Therapeutics, Inc.
  11.10.1 Company Overview
  11.10.2 Revenue Analysis
  11.10.3 Product Portfolio
  11.10.4 Recent Developments
11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.)
  11.11.1 Company Overview
  11.11.2 Geographicpresence
  11.11.3 Product Portfolio
  11.11.4 Recent Developments
11.12 Kerecis
  11.12.1 Company Overview
  11.12.2 Geographical Presence
  11.12.3 Product Portfolio
  11.12.4 Recent Developments
11.13 Marine Polymer Technologies, Inc
  11.13.1 Company Overview
  11.13.2 Product Portfolio
  11.13.3 Recent Developments
11.14 Mölnlycke Health Care Ab
  11.14.1 Company Overview
  11.14.2 Revenue Analysis
  11.14.3 Product Portfolio
  11.14.4 Recent Developments
11.15 Osiris Therapeutics, Inc.
  11.15.1 Company Overview
  11.15.2 Revenue Analysis
  11.15.3 Product Portfolio
  11.15.4 Recent Developments
11.16 Skye Biologics Inc.
  11.16.1 Company Overview
  11.16.2 Product Portfolio:
  11.16.3 Recent Development:
11.17 Smith And Nephew
  11.17.1 Company Overview
  11.17.2 Revenue Analysis
  11.17.3 Product Portfolio
  11.17.4 Recent Developments
11.18 Solsys Medical.
  11.18.1 Company Overview
  11.18.2 Product Portfolio
  11.18.3 Recent Developments
11.19 Vericel Corporation.
  11.19.1 Company Overview
  11.19.2 1.1.2 Revenue Analysis
  11.19.3 Product Portfolio
  11.19.4 Recent Developments
11.20 Wright Medical Group N.V
  11.20.1 Company Overview
  11.20.2 1.1.2 Revenue Analysis
  11.20.3 Product Portfolio
  11.20.4 Recent Developments

12 RELATED REPORTS

List Of Figures

LIST OF FIGURES

Figure 1 Global Wound Care Biologics Market: Segmentation
Figure 2 Global Wound Care Biologics Market: Data Triangulation
Figure 3 Global Wound Care Biologics Market: Research Snapshot
Figure 4 Global Wound Care Biologics Market: Bottom Up Approach
Figure 5 Global Wound Care Biologics Market: Top Down Approach
Figure 6 Global Wound Care Biologics Market: Interview Demographics
Figure 1 Global Wound Care Biologics Market: Dbmr Market Position Grid
Figure 2 Global Wound Care Biologics Market: The Market Challenge Matrix
Figure 3 Drivers, Restraints, Opportunities And Challenges Of Global Wound Care Biologics Market
Figure 4 Aging Population In Different Countries (2014, 2017 & 2020)
Figure 5 Global Wound Care Biologics Market: Segmentation
Figure 6 North America Is Anticipated To Dominate The Global Wound Care Biologics Market And Asia Pacific Is Estimated To Be Increasing With The Strong Cagr In The Forecast Period From 2018 To 2025
Figure 7 Increasing Prevelance Of Diabetic Foot Ulcers And Increasing Incidences Of Burn Cases Are Expected To Drive The Market For Global Wound Care Biologics In The Forecast Period 2018 To 2025
Figure 8 Synthetic Skin Grafts In Global Wound Care Biologics Is Expected To Account For The Largest Share Of The Global Wound Care Biologics Market In 2018 & 2025
Figure 9 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For Global Wound Care Biologics Market In The Forecast Period From 2018 To 2025
Figure 10 Worldwide Prevalence Of Various Wound Types, 2011
Figure 11 Cases Of Burn Injuries, (2009 – 2012)
Figure 12 Prevalence Of Pressure Ulcers In Few Countries
Figure 13 Number Of Surgical Procedures And Surgical Site Infections
Figure 14 Global Wound Care Biologics Market: By Product Type, 2017
Figure 15 Global Wound Care Biologics Market: By Wound Type, 2017
Figure 16 Global Wound Care Biologics Market: By End User, Snapshot 2017
Figure 17 Global Wound Care Biologics Market: Snapshot (2017)
Figure 18 Global Wound Care Biologics Market: By Country (2017)
Figure 19 Global Wound Care Biologics Market: By Country (2018 & 2025)
Figure 20 Global Wound Care Biologics Market, By Country (2017 & 2025)
Figure 21 Global Wound Care Biologics Market, By Product Type (2018 -2025)
Figure 22 North America Wound Care Biologics Market: Snapshot (2017)
Figure 23 North America Wound Care Biologics Market: By Country (2017)
Figure 24 North America Wound Care Biologics Market: By Country (2018 & 2025)
Figure 25 North America Wound Care Biologics Market, By Country (2017 & 2025)
Figure 26 North America Wound Care Biologics Market, By Product Type (2018 -2025)
Figure 27 Europe Wound Care Biologics Market: Snapshot (2017)
Figure 28 Europe Wound Care Biologics Market: By Country (2017)
Figure 29 Europe Wound Care Biologics Market: By Country (2018 & 2025)
Figure 30 Europe Wound Care Biologics Market, By Country (2017 & 2025)
Figure 31 Europe Wound Care Biologics Market, By Product Type (2018 -2025)
Figure 32 Asia-Pacific Wound Care Biologics Market: Snapshot (2017)
Figure 33 Asia-Pacific Wound Care Biologics Market: By Country (2017)
Figure 34 Asia-Pacific Wound Care Biologics Market: By Country (2018 & 2025)
Figure 35 Asia-Pacific Wound Care Biologics Market, By Country (2017 & 2025)
Figure 36 Asia-Pacific Wound Care Biologics Market, By Product Type (2018 -2025)
Figure 37 South America Wound Care Biologics Market: Snapshot (2017)
Figure 38 South America Wound Care Biologics Market: By Country (2017)
Figure 39 South America Wound Care Biologics Market: By Country (2018 & 2025)
Figure 40 South America Wound Care Biologics Market, By Country (2017 & 2025)
Figure 41 South America Wound Care Biologics Market, By Product Type (2018 -2025)
Figure 42 Middle East & Africa Wound Care Biologics Market: Snapshot (2017)
Figure 43 Middle East & Africa Wound Care Biologics Market: By Country (2017)
Figure 44 Middle East & Africa Wound Care Biologics Market: By Country (2018 & 2025)
Figure 45 Middle East & Africa Wound Care Biologics Market, By Country (2017 & 2025)
Figure 46 Middle East & Africa Wound Care Biologics Market, By Product Type (2018 -2025)
Figure 47 Global Wound Care Biologics Market: Company Share 2017 (%)
Figure 48 North America Wound Care Biologics Market: Company Share 2017 (%)
Figure 49 Europe Wound Care Biologics Market: Company Share 2017 (%)
Figure 50 Asia-Pacific Wound Care Biologics Market: Company Share 2017 (%)